MDR 2017/745: Key Obligations for Medical Device Distributors

The Medical Device Regulation (MDR, EU 2017/745) redefines your role. You are no longer a mere intermediary, but a key player in patient safety and product compliance. This article details your verification, traceability, and vigilance obligations to enable you to operate in full compliance.

Understanding Regulation (EU) 2017/745 (MDR) and its impact on distributors

The MDR (EU) 2017/745 regulation makes you, the distributor, an economic operator co-responsible for the conformity of medical devices. Fully applicable since May 2021, it harmonizes European legislation and imposes proactive verification and vigilance duties on you, alongside manufacturers and importers ^[S5]. This change is fundamental.

From reseller to responsible economic operator

Your role evolves from a simple reseller to an economic operator with clear legal obligations. The MDR aims to increase transparency and safety throughout the product lifecycle. Specifically, you must actively ensure that the products you manage comply with regulatory requirements before making them available. This responsibility requires a perfect understanding of the regulations, as detailed in our comprehensive guide to medical device regulation.

General obligations of the medical device distributor

Your primary obligation is to verify that each medical device meets key regulatory requirements before placing it on the market. This verification includes CE marking, the EU declaration of conformity, the assignment of a UDI code, as well as the conformity of the labeling and instructions for use ^[S1]. You must also ensure that your storage or transport conditions do not alter the integrity of the device.

These controls constitute a first line of defense for patient safety. You must act diligently and document your procedures. In case of doubt about the conformity of a device, it is prohibited to place it on the market. You then have a duty to immediately inform the manufacturer, their authorized representative, the importer, and the competent authorities.

Distributor Verification Checklist before Making Available on the Market (Article 14 MDR)

To systematize these controls, the use of a checklist is an essential practice. The following table details the essential control points.

Specific obligations in case of device modification or information translation

If you modify a device, translate its instructions, or market it under your own name, you assume the same responsibilities as a manufacturer. These actions, governed by Article 16 of the MDR, can affect the conformity and safety of the initial product ^[S2].

In these cases, you must implement a quality management system (QMS) to oversee these activities. You must also inform the manufacturer and the competent authority at least 28 days before making it available, and provide samples of the modified labeling upon request. Your name and address must then appear on the labeling ^[S3].

The crucial role of the quality management system for distributors

A quality management system (QMS) is your best tool to ensure and prove that your operations preserve the conformity of devices. Although a certification like ISO 13485 is not always mandatory for distribution, it becomes so if you modify the packaging or translate the information of a device ^[S2].

The pillars of a QMS for distributors

A robust QMS structures and documents your key processes:

• Product reception and control: Procedures for systematic verification.
• Storage conditions: Monitoring and recording of parameters (temperature, humidity), and separation of non-conforming products.
• Inventory management: Application of FIFO (First In, First Out) or FEFO (First Expired, First Out) rules.
• Traceability: Recording of UDI and product movements.
• Non-conformity management: Procedure for isolating, documenting, and processing suspicious products.
• Handling complaints and returns: Process for recording, investigating, and transmitting information to the manufacturer.

This is a pillar of effective management of a B2B medical supply system.

Collaboration and communication: the importance of exchanges with manufacturers and authorities

You are an essential information relay between users, manufacturers, and authorities. You must immediately transmit any complaint or suspected incident to the manufacturer. This collaboration is fundamental for materiovigilance and the rapid identification of risks ^[S7].

Furthermore, you must cooperate fully with competent authorities such as the ANSM. This includes providing all necessary documentation, allowing access to your premises for inspection, and implementing requested corrective measures (withdrawal, recall) without delay. Transparent and reactive communication with all parties is essential.

Consequences of non-compliance with the MDR for distributors

Ignoring your MDR obligations exposes you to major risks. This is not just an administrative risk, but a commercial and criminal issue.

• Legal and financial sanctions: Significant administrative fines, or even legal proceedings in case of harm to a patient.
• Operational measures: Obligation to withdraw non-compliant products or carry out costly recalls.
• Reputational risk: Loss of trust from customers and partners, potentially leading to contract termination and lasting damage to your image.

Market surveillance authorities have extensive investigative and sanctioning powers. Compliance is therefore not an option, but an essential condition for operating.

Best practices for successful and sustainable compliance

To ensure sustainable MDR compliance, adopt a proactive and structured approach. Simply reacting to problems is insufficient and risky.

Here are some concrete actions to implement:

• Establish registers: Maintain an electronic register of complaints, non-compliant devices, recalls, and withdrawals.
• Systematize traceability: Use a system capable of quickly recording and retrieving UDIs to know who supplied you with the device and to whom you delivered it.
• Qualify suppliers: Establish a qualification procedure for each supplier, requiring the EU declaration of conformity and EU conformity certificates.
• Train teams: Organize regular training for your teams on the MDR requirements that directly concern them.
• Conduct self-assessments: Conduct internal audits to verify the application of your procedures and identify areas for improvement.

Frequently Asked Questions

What are the main responsibilities of a medical device distributor according to MDR 2017/745?

Your key responsibilities are to verify the conformity of devices before placing them on the market (CE marking, UDI, labeling), ensure good storage conditions, ensure traceability, manage complaints, and cooperate with manufacturers and competent authorities ^[S1].

In what cases can a distributor be assimilated to a manufacturer according to the MDR?

You are considered a manufacturer if you place a device on the market under your own name, or if you modify it in a way that could affect its conformity, for example by repackaging it or translating its instructions without complying with the strict conditions of Article 16 of the MDR ^[S3].

How should a distributor manage non-conformities or incidents related to medical devices?

If you suspect a device is non-compliant, you must isolate it to stop its distribution and inform the manufacturer, their authorized representative, and the importer. You must record all complaints and incidents and transmit them without delay for investigation ^[S7].

Is it mandatory for a distributor to have a certified quality management system?

No, it is not mandatory for standard distribution activities. However, a certified QMS becomes a requirement if you translate information or repackage a device, to ensure that its conformity is preserved ^[S2].

What are the traceability requirements for medical device distributors?

You must be able to identify the operator who supplied you with a device and the one to whom you delivered it. You must store the UDI of class III implantable devices. These traceability data must be kept for at least 10 years after the last device concerned was placed on the market (15 years for implantable devices) ^[S5].